FIELD: medicine, pharmaceutics.
SUBSTANCE: described are derivatives of 5H-pyrazolo[1,5-c][1,3]benzoxasin-5-yl)phenylmethanon of formula , possessing ability to inhibit HIV replication, where values of R1, R2, R3 substitutes are given in invention formula. Also describes is pharmaceutical preparation and application of compound for obtaining medication applied for treatment of conditions associated with HIV infection.
EFFECT: claimed compounds are applicable for prevention or treatment of HIV-produced infection and for AIDS treatment.
15 cl, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
(1,10b-DIHYDRO-2-(AMINOALKYLPHENYL)-5H-PYRAZOLO[1,5-c][1,3] BENZOXAZIN-5-YL) PHENYLMETHANONE DERIVATIVES AS HIV VIRAL REPLICATION INHIBITORS | 2006 |
|
RU2416615C2 |
MACROCYCLIC HEPATITIS TYPE C VIRUS INHIBITORS | 2006 |
|
RU2419619C2 |
HIV-INHIBITING 5-(HYDROXYMETHYLENE- AND AMINOMETHYLENE)SUBSTITUTED PYRIMIDINES | 2007 |
|
RU2452737C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | 2005 |
|
RU2401269C2 |
CONDENSED HETEROCYCLIC COMPOUND | 2009 |
|
RU2480473C2 |
COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER | 2007 |
|
RU2452492C2 |
HETEROCYCLIC COMPOUNDS HAVING 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITING ACTIVITY | 2006 |
|
RU2443689C2 |
OBTAINING DIHYDROTHIENO[3,2-d]PYRIMIDINES AND INTERMEDIATE PRODUCTS, APPLIED FOR THEIR SYNTHESIS | 2008 |
|
RU2528340C2 |
THIOLSULFONAMIDE INHIBITORS OF METALLOPROTEASE | 1997 |
|
RU2202540C2 |
Authors
Dates
2010-02-27—Published
2005-05-04—Filed